0001235802-23-000071.txt : 20230626
0001235802-23-000071.hdr.sgml : 20230626
20230626162641
ACCESSION NUMBER: 0001235802-23-000071
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230623
FILED AS OF DATE: 20230626
DATE AS OF CHANGE: 20230626
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Semba Charles Pauling
CENTRAL INDEX KEY: 0001872863
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36291
FILM NUMBER: 231042681
MAIL ADDRESS:
STREET 1: TWO CARLSON PARKWAY, SUITE 260
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55447
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DiaMedica Therapeutics Inc.
CENTRAL INDEX KEY: 0001401040
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: Z4
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 CARLSON PARKWAY
STREET 2: SUITE 210
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55305
BUSINESS PHONE: (763) 496-5454
MAIL ADDRESS:
STREET 1: 301 CARLSON PARKWAY
STREET 2: SUITE 210
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55305
FORMER COMPANY:
FORMER CONFORMED NAME: DiaMedica Inc.
DATE OF NAME CHANGE: 20070525
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0407
4
2023-06-23
0
0001401040
DiaMedica Therapeutics Inc.
DMAC
0001872863
Semba Charles Pauling
301 CARLSON PARKWAY, SUITE 210
MINNEAPOLIS
MN
55305
1
0
0
0
0
Voting Common Shares, no par value per share
2023-06-23
4
P
0
12787
3.91
A
29943
D
Includes 12,867 shares issuable on vesting of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan.
/s/ Amy E. Culbert, attorney-in-fact
2023-06-26